Shifting breast cancer trends in the United States

Journal of Clinical Oncology

Volumn 25, Issue 25, 2007, Pages 3923-3929

  Anderson, William F ^a,b   Reiner, Anne S ^a   Matsuno, Rayna K ^a   Pfeiffer, Ruth M ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANALYTIC METHOD; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER PATIENT; CANCER REGISTRY; CANCER SCREENING; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; PRIORITY JOURNAL; UNITED STATES; AGE DISTRIBUTION; BREAST TUMOR; CARCINOMA IN SITU; INCIDENCE; LYMPH NODE METASTASIS; MIDDLE AGED; ONSET AGE; STATISTICAL MODEL;

AGE DISTRIBUTION; AGE OF ONSET; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA IN SITU; FEMALE; HUMANS; INCIDENCE; LYMPHATIC METASTASIS; MIDDLE AGED; MODELS, STATISTICAL; UNITED STATES;

EID: 34548538157     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2007.11.6079     Document Type: Article

References (34)

1. Ries LAG, Melbert D, Krapcho M, et al: SEER Cancer Statistics Review, 1975-2004, National Cancer Institute Bethesda, MD, based on November 2006 SEER data submission, posted to the SEER Web site, 2007. http://seer.cancer.gov/
2. Howe HL, Wu X, Ries LA, et al: Annual report to the nation on the status of cancer, 1975-2003, featuring cancer among U.S. Hispanic/Latino populations. Cancer 107:1711-1742, 2006
3. Clarke CA, Glaser SL, Uratsu CS, et al: Recent declines in hormone therapy utilization and breast cancer incidence: Clinical and population-based evidence. J Clin Oncol 24:e49-e50, 2006
4. Ravdin PM, Cronin KA, Howlader N, et al: The decrease in breast-cancer incidence in 2003 in the United States. N Engl J Med 356:1670-1674, 2007
5. McNeil C: Breast cancer decline mirrors fall in hormone use, spurs both debate and research. J Natl Cancer Inst 99:266-267, 2007
6. Hersh AL, Stefanick ML, Stafford RS: National use of postmenopausal hormone therapy: Annual trends and response to recent evidence. JAMA 291:47-53, 2004
7. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial. JAMA 288:321-333, 2002
8. Glaser SL, Clarke CA, Gomez SL, et al: Cancer surveillance research: A vital subdiscipline of cancer epidemiology. Cancer Causes Control 16:1009-1019, 2005
9. SEER: Surveillance, Epidemiology, and End Results (SEER) Program. SEER*Stat Database: Incidence-Connecticut Historical, Aug 1999 Sub (1935-1997), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, 2006. http://seer.cancer.gov/
10. Anderson WF, Jatoi I, Devesa SS: Assessing the impact of screening mammography: Breast cancer incidence and mortality rates in Connecticut (1943-2002). Breast Cancer Res Treat 99:333-340, 2006
11. Silverman BW: Density Estimation for Statistics and Data Analysis. London, United Kingdom, Chapman and Hall, 1986
12. Anderson WF, Chatterjee N, Ershler WB, et al: Estrogen receptor breast cancer phenotypes in the Surveillance, Epidemiology, and End results database. Breast Cancer Res Treat 76:27-36, 2002
13. Gallant AR, Nychka DW: Semi-nonparametric maximum likelihood estimation. Econometrica 55:363-390, 1987
14. Akaike H: Information theory and an extension of the maximum likelihood principle, in Petrov BN, Csaki F (eds): 2nd International Symposium on Information Theory. Budapest, Hungary, 1973, pp 267-281
15. Pfeiffer RM, Gail MH, Brown LM: Probability of Helicobacter pylori infection based on IgG levels and other covariates using a mixture model. J Epidemiol Biostat 5:267-275, 2000
16. Anderson WF, Pfeiffer RM, Dores GM, et al: Comparison of age frequency distribution patterns for different histopathologic types of breast carcinoma. Cancer Epidemiol Biomarkers Prev 15:1899-1905, 2006
17. Pfeiffer RM, Carroll RJ, Wheeler W, et al: Combining assays for estimating prevalence of human herpesvirus 8 infection using multivariate mixture models. Biostatistics (in press)
18. Clemmesen J: Carcinoma of the breast. Br J Radiol 21:583-590, 1948
19. Lilienfeld AM, Johnson EA: The age distribution in female breast and genital cancers. Cancer 8:875-882, 1955
20. Feuer EJ: Modeling the impact of adjuvant therapy and screening mammography on U.S. Breast cancer mortality between 1975 and 2000: Introduction to the problem. J Natl Cancer Inst Monogr 36:2-6, 2006
21. Chu KC, Tarone RE, Kessler LG, et al: Recent trends in U.S. breast cancer incidence, survival, and mortality rates. J Natl Cancer Inst 88:1571-1579, 1996
22. Tarone RE: Breast cancer trends among young women in the United States. Epidemiology 17:588-590, 2006
23. Holford TR, Cronin KA, Mariotto AB, et al: Changing patterns in breast cancer incidence trends. J Natl Cancer Inst Monogr 19-25, 2006
24. Fox MS: On the diagnosis and treatment of breast cancer. JAMA 241:489-494, 1979
25. Adami H-O: Breast cancer incidence and mortality: Aspects on aetiology, time trends and curability. Acta Chir Scand 519:9-14, 1984 (suppl)
26. Ernster VL, Ballard-Barbash R, Barlow WE, et al: Detection of ductal carcinoma in situ in women undergoing screening mammography. J Natl Cancer Inst 94:1546-1554, 2002
27. Hemminki K, Rawal R, Bermejo JL: Mammographic screening is dramatically changing age-incidence data for breast cancer. J Clin Oncol 22:4652-4653, 2004
28. Hemminki K, Bermejo JL: Effects of screening for breast cancer on its age-incidence relationships and familial risk. Int J Cancer 117:145-149, 2005
29. Jonsson H, Johansson R, Lenner P: Increased incidence of invasive breast cancer after the introduction of service screening with mammography in Sweden. Int J Cancer 117:842-847, 2005
30. Swan J, Breen N, Coates RJ, et al: Progress in cancer screening practices in the United States: Results from the 2000 National Health Interview Survey. Cancer 97:1528-1540, 2003
31. Parkin DM, Bray FI, Devesa SS: Cancer burden in the year 2000: The global picture. Eur J Cancer 37:S4-S66, 2001
32. Anderson WF, Jatoi I, Devesa SS: Distinct breast cancer incidence and prognostic patterns in the NCI's SEER program: Suggesting a possible link between etiology and outcome. Breast Cancer Res Treat 90:127-137, 2005
33. Burstein HJ, Winer EP: HER2 or not HER2: That is the question. J Clin Oncol 23:3656-3659, 2005
34. Anderson WF, Matsuno RK: Breast cancer heterogeneity: A mixture of at least two main types? J Natl Cancer Inst 98:948-951, 2006